Non-Invasive Monitoring Systems, Inc. is a medical technology company that researches, designs, develops, and markets non-invasive diagnostic monitoring instruments and therapeutic motion devices for clinical and home healthcare applications. The company's product portfolio comprises whole-body periodic acceleration (WBPA) therapeutic platforms, including the Exer-Rest passive exercise bed and AT-series motion delivery platforms engineered to impart periodic acceleration forces to the human body, stimulate endothelial nitric oxide production, enhance regional blood flow, and support cardiopulmonary and microvascular function in immobile or exercise-limited patients; respiratory inductive plethysmography (RIP) diagnostic systems, including Respitrace non-invasive ventilation and breathing pattern monitors; thoracic and abdominal transducer bands, calibration modules, and sleep disorder diagnostic interfaces; neonatal, pediatric, and adult continuous respiration monitoring sensors; and associated diagnostic analysis software, replacement components, disposable transducer accessories, and technical support services. Non-Invasive Monitoring Systems, Inc. markets its solutions to hospitals, academic medical centers, sleep diagnostic clinics, pulmonary rehabilitation facilities, long-term nursing facilities, and individual home users throughout North America and international territories via direct sales and distributor relationships. In recent company developments, the company enacted a corporate share consolidation and reverse stock split that resulted in the temporary assignment of its OTC ticker symbol to NIMUD from NIMU, accompanied by operational restructuring initiatives aimed at expanding commercial distribution partnerships and scaling direct-to-consumer accessibility for its acceleration therapy and cardiopulmonary wellness platforms. Founded in 1980, Non-Invasive Monitoring Systems, Inc. is headquartered in North Bay Village, Florida.